Shopping Cart
- Remove All
- Your shopping cart is currently empty
Glycolate oxidase-IN-1 (compound 26), a salicylic acid derivative, serves as an inhibitor of glycolate oxidase (GO) and exhibits an inhibitory concentration (IC50) of 38.2 μM. It is efficacious in reducing oxalate production in hyperoxaluric hepatocytes and has potential applications in researching primary hyperoxaluria type 1 (PH1) [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | Glycolate oxidase-IN-1 (compound 26), a salicylic acid derivative, serves as an inhibitor of glycolate oxidase (GO) and exhibits an inhibitory concentration (IC50) of 38.2 μM. It is efficacious in reducing oxalate production in hyperoxaluric hepatocytes and has potential applications in researching primary hyperoxaluria type 1 (PH1) [1]. |
In vitro | When treated with Glycolate oxidase-IN-1 (compound 26) (0-12.5 μM, 48 h), murine hepatocytes exhibited a significant reduction in excreted oxalate levels, with a 67.3 ± 32% decrease observed at a concentration of 6.25 μM. |
Molecular Weight | 232.19 |
Formula | C12H8O5 |
Cas No. | 330977-65-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.